Leveraging chimeric antigen receptor–T cell therapy for the treatment of multiple sclerosis: Bridging oncology and neurology

Matlyuba Sanoyeva, Nargiza Nasirdinova, Munisakhon Gulova, Nargiza Ortikova, Alexey Yumashev, Ro'zibek Tolmasov, Turgunbay Kholdarov, Zhanna R. Gardanova

Open source

DOI: 10.1016/j.retram.2026.103603
Published: 2026-07
Container: Current Research in Translational Medicine
Publisher: Elsevier BV
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1016/j.retram.2026.103603,
  title = {Leveraging chimeric antigen receptor–T cell therapy for the treatment of multiple sclerosis: Bridging oncology and neurology},
  author = {Matlyuba Sanoyeva and Nargiza Nasirdinova and Munisakhon Gulova and Nargiza Ortikova and Alexey Yumashev and Ro'zibek Tolmasov and Turgunbay Kholdarov and Zhanna R. Gardanova},
  year = {2026},
  journal = {Current Research in Translational Medicine},
  doi = {10.1016/j.retram.2026.103603},
  url = {https://doi.org/10.1016/j.retram.2026.103603}
}

RIS

TY  - JOUR
TI  - Leveraging chimeric antigen receptor–T cell therapy for the treatment of multiple sclerosis: Bridging oncology and neurology
AU  - Matlyuba Sanoyeva
AU  - Nargiza Nasirdinova
AU  - Munisakhon Gulova
AU  - Nargiza Ortikova
AU  - Alexey Yumashev
AU  - Ro'zibek Tolmasov
AU  - Turgunbay Kholdarov
AU  - Zhanna R. Gardanova
PY  - 2026
JO  - Current Research in Translational Medicine
DO  - 10.1016/j.retram.2026.103603
UR  - https://doi.org/10.1016/j.retram.2026.103603
ER  -

APA

Sanoyeva, M., Nasirdinova, N., Gulova, M., Ortikova, N., Yumashev, A., Tolmasov, R., Kholdarov, T., & Gardanova, Z. R. (2026). Leveraging chimeric antigen receptor–T cell therapy for the treatment of multiple sclerosis: Bridging oncology and neurology. Current Research in Translational Medicine. https://doi.org/10.1016/j.retram.2026.103603

Source records

crossref · retrieved 2026-09-26T15:40:16.405Z